BioRestorative Therapies was founded by scientists and researchers committed to developing stem cell therapies to address unmet needs in patients with highly prevalent conditions.
Our advances in stem cell biology and delivery protocols harbor great promise in conditioning our bodies’ own regenerative potential to treat major diseases more effectively than current interventions.
Today, BioRestorative is actively developing programs that aim to dramatically increase quality of care for both;
(i) chronic back pain caused by disc degeneration, as well as
(ii) metabolic disorders including obesity and diabetes.
To target obesity and metabolic disorders, we’ve developed our ThermoStem® program that uses brown adipose-derived (“brown fat”) stem cells to generate new brown fat tissue. BioRestorative Therapies was one of the first companies to identify and publish data about this novel stem cell population. This population of fat is known to burn, rather than store, energy. Elevated levels of brown fat have been demonstrated to increase metabolism and facilitate weight loss.
Initial preclinical research indicates that increased amounts of activated brown fat in the body may be responsible for additional caloric burning, as well as reduced glucose and lipid levels. Further, researchers have found that people with higher levels of brown fat may have a reduced risk for obesity and diabetes.